Protalix BioTherapeutics, Inc. - COM (PLX)

Historical Portfolio Holders from Q4 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
9.27 M
Holdings value Q1 2024
$11.7 M
Value change Q1 2024
-$600 K
Grand Portfolio weight change Q1 2024
0%
Number of holders
60
Number of buys Q1 2024
23
Number of sells Q1 2024
-30
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
74365A309
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 9.27 M $11.7 M -$600 K $1.26 60
2023 Q4 9.6 M $17.1 M +$1.15 M $1.78 65
2023 Q3 9.17 M $15.2 M -$99.2 K $1.66 61
2023 Q2 8.97 M $17.9 M +$12 M $2.00 65
2023 Q1 2.94 M $6.15 M +$408 K $2.10 34
2022 Q4 3.57 M $4.87 M +$112 K $1.37 27
2022 Q3 3.55 M $3.7 M +$2.4 M $1.04 25
2022 Q2 1.19 M $1.3 M +$26.7 K $1.09 28
2022 Q1 1.22 M $1.29 M -$1.77 M $1.06 28
2021 Q4 2.91 M $2.43 M -$1.66 M $0.83 22
2021 Q3 4.4 M $5.9 M +$96.8 K $1.33 33
2021 Q2 4.31 M $8.23 M -$19.3 M $1.91 29
2021 Q1 8.82 M $39.3 M +$21.2 M $4.46 35
2020 Q4 3.94 M $14.3 M -$2.67 M $3.63 20
2020 Q3 4.76 M $18.4 M -$1.92 M $3.87 25
2020 Q2 5.26 M $19.8 M -$2.82 M $3.79 25
2020 Q1 6 M $14.1 M +$12.6 M $2.35 15
2019 Q4 644 K $2.11 M +$2.11 M $3.28 7